These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 35063631)

  • 1. Diaryl triazenes inhibit cytochrome P450 1A1 and 1B1 more strongly than aryl morpholino triazenes.
    Moran R; Nakamura R; Isovitsch R; Iimoto D
    Bioorg Med Chem Lett; 2022 Mar; 59():128570. PubMed ID: 35063631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aryl morpholino triazenes inhibit cytochrome P450 1A1 and 1B1.
    Lee D; Perez P; Jackson W; Chin T; Galbreath M; Fronczek FR; Isovitsch R; Iimoto DS
    Bioorg Med Chem Lett; 2016 Jul; 26(14):3243-3247. PubMed ID: 27265259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-function relationships of inhibition of human cytochromes P450 1A1, 1A2, 1B1, 2C9, and 3A4 by 33 flavonoid derivatives.
    Shimada T; Tanaka K; Takenaka S; Murayama N; Martin MV; Foroozesh MK; Yamazaki H; Guengerich FP; Komori M
    Chem Res Toxicol; 2010 Dec; 23(12):1921-35. PubMed ID: 21053930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel Synthetic Analogues of 19(S/R)-Hydroxyeicosatetraenoic Acid Exhibit Noncompetitive Inhibitory Effect on the Activity of Cytochrome P450 1A1 and 1B1.
    Shoieb SM; Dakarapu R; Falck JR; El-Kadi AOS
    Eur J Drug Metab Pharmacokinet; 2021 Sep; 46(5):613-624. PubMed ID: 34235626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of human cytochrome P450 1A1-, 1A2-, and 1B1-mediated activation of procarcinogens to genotoxic metabolites by polycyclic aromatic hydrocarbons.
    Shimada T; Guengerich FP
    Chem Res Toxicol; 2006 Feb; 19(2):288-94. PubMed ID: 16485905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitors of cytochrome P450 (CYP) 1B1.
    Dutour R; Poirier D
    Eur J Med Chem; 2017 Jul; 135():296-306. PubMed ID: 28458135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spectral modification and catalytic inhibition of human cytochromes P450 1A1, 1A2, 1B1, 2A6, and 2A13 by four chemopreventive organoselenium compounds.
    Shimada T; Murayama N; Tanaka K; Takenaka S; Guengerich FP; Yamazaki H; Komori M
    Chem Res Toxicol; 2011 Aug; 24(8):1327-37. PubMed ID: 21732699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different mechanisms for inhibition of human cytochromes P450 1A1, 1A2, and 1B1 by polycyclic aromatic inhibitors.
    Shimada T; Murayama N; Okada K; Funae Y; Yamazaki H; Guengerich FP
    Chem Res Toxicol; 2007 Mar; 20(3):489-96. PubMed ID: 17291012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dibenzyl trisulfide binds to and competitively inhibits the cytochrome P450 1A1 active site without impacting the expression of the aryl hydrocarbon receptor.
    Wauchope S; Roy MA; Irvine W; Morrison I; Brantley E; Gossell-Williams M; Timme-Laragy AR; Delgoda R
    Toxicol Appl Pharmacol; 2021 May; 419():115502. PubMed ID: 33774063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The synthesis of 4,6-diaryl-2-pyridones and their bioactivation in CYP1 expressing breast cancer cells.
    Ruparelia KC; Lodhi S; Ankrett DN; Wilsher NE; Arroo RRJ; Potter GA; Beresford KJM
    Bioorg Med Chem Lett; 2019 Jun; 29(11):1403-1406. PubMed ID: 30935796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting Cytochrome P450 (CYP) 1B1 Enzyme with Four Series of A-Ring Substituted Estrane Derivatives: Design, Synthesis, Inhibitory Activity, and Selectivity.
    Dutour R; Roy J; Cortés-Benítez F; Maltais R; Poirier D
    J Med Chem; 2018 Oct; 61(20):9229-9245. PubMed ID: 30216063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selectivity of polycyclic inhibitors for human cytochrome P450s 1A1, 1A2, and 1B1.
    Shimada T; Yamazaki H; Foroozesh M; Hopkins NE; Alworth WL; Guengerich FP
    Chem Res Toxicol; 1998 Sep; 11(9):1048-56. PubMed ID: 9760279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular Cloning, Tissue Distribution, and Functional Characterization of Marmoset Cytochrome P450 1A1, 1A2, and 1B1.
    Uehara S; Uno Y; Inoue T; Sasaki E; Yamazaki H
    Drug Metab Dispos; 2016 Jan; 44(1):8-15. PubMed ID: 26502772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Activation of Procarcinogens by CYP1A1/1B1 and Related Chemo-Preventive Agents: A Review.
    Li Y; Cui J; Jia J
    Curr Cancer Drug Targets; 2021; 21(1):21-54. PubMed ID: 33023449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2,3,7,8-Tetrachlorodibenzo-p-dioxin and diindolylmethanes differentially induce cytochrome P450 1A1, 1B1, and 19 in H295R human adrenocortical carcinoma cells.
    Sanderson JT; Slobbe L; Lansbergen GW; Safe S; van den Berg M
    Toxicol Sci; 2001 May; 61(1):40-8. PubMed ID: 11294972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potent inhibition of human cytochrome P450 1 enzymes by dimethoxyphenylvinyl thiophene.
    Lee SK; Kim Y; Kim MY; Kim S; Chun YJ
    Arch Pharm Res; 2004 Feb; 27(2):199-205. PubMed ID: 15022723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioactivation of diesel exhaust particle extracts and their major nitrated polycyclic aromatic hydrocarbon components, 1-nitropyrene and dinitropyrenes, by human cytochromes P450 1A1, 1A2, and 1B1.
    Yamazaki H; Hatanaka N; Kizu R; Hayakawa K; Shimada N; Guengerich FP; Nakajima M; Yokoi T
    Mutat Res; 2000 Dec; 472(1-2):129-38. PubMed ID: 11113705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pyranoflavones: a group of small-molecule probes for exploring the active site cavities of cytochrome P450 enzymes 1A1, 1A2, and 1B1.
    Liu J; Taylor SF; Dupart PS; Arnold CL; Sridhar J; Jiang Q; Wang Y; Skripnikova EV; Zhao M; Foroozesh M
    J Med Chem; 2013 May; 56(10):4082-92. PubMed ID: 23600958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relative effect potency estimates of dioxin-like activity for dioxins, furans, and dioxin-like PCBs in adults based on cytochrome P450 1A1 and 1B1 gene expression in blood.
    Wimmerová S; van den Berg M; Chovancová J; Patayová H; Jusko TA; van Duursen MB; Palkovičová Murínová Ľ; Canton RF; van Ede KI; Trnovec T
    Environ Int; 2016 Nov; 96():24-33. PubMed ID: 27588699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of human cytochrome P450 1B1, 1A1 and 1A2 by antigenotoxic compounds, purpurin and alizarin.
    Takahashi E; Fujita K; Kamataki T; Arimoto-Kobayashi S; Okamoto K; Negishi T
    Mutat Res; 2002 Oct; 508(1-2):147-56. PubMed ID: 12379470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.